2017
DOI: 10.1111/febs.14029
|View full text |Cite
|
Sign up to set email alerts
|

Targeting proteasomes in infectious organisms to combat disease

Abstract: Proteasomes are multisubunit, energy-dependent, proteolytic complexes that play an essential role in intracellular protein turnover. They are present in eukaryotes, archaea, and in some actinobacteria species. Inhibition of proteasome activity has emerged as a powerful strategy for anticancer therapy and three drugs have been approved for treatment of multiple myeloma. These compounds react covalently with a threonine residue located in the active site of a proteasome subunit to block protein degradation. Prot… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
40
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 47 publications
(44 citation statements)
references
References 114 publications
0
40
0
Order By: Relevance
“…However, in contrast to Pst infection, MG132 treatment is still sufficient to inactivate the proteasome in atg mutants (Marshall et al, 2016), suggesting different modes of HopM1 and MG132 action. Indeed, HopM1 is mainly associated with the regulatory particle of the 26S proteasome (Üstün et al, 2016), while MG132 targets its catalytic subunits (Bibo-Verdugo et al, 2017). Hence, an efficient block of proteasome activity during Pst infection requires a functional proteaphagy pathway involving the core autophagy machinery (ATG2, ATG5, and ATG7) and cargo receptor (RPN10).…”
Section: Discussionmentioning
confidence: 99%
“…However, in contrast to Pst infection, MG132 treatment is still sufficient to inactivate the proteasome in atg mutants (Marshall et al, 2016), suggesting different modes of HopM1 and MG132 action. Indeed, HopM1 is mainly associated with the regulatory particle of the 26S proteasome (Üstün et al, 2016), while MG132 targets its catalytic subunits (Bibo-Verdugo et al, 2017). Hence, an efficient block of proteasome activity during Pst infection requires a functional proteaphagy pathway involving the core autophagy machinery (ATG2, ATG5, and ATG7) and cargo receptor (RPN10).…”
Section: Discussionmentioning
confidence: 99%
“…Several bacterial, viral, protozoan and fungal proteases trigger inflammation by activating the intrinsic coagulation pathway [102], or act as procoagulants by non-canonical, direct activation of prothrombin [179]. Large panels of small-molecule inhibitors of the proteasome in pathogenic organisms are currently being screened for potential therapeutic benefit and minimal toxicity toward the cellular machinery of the host [180]. Bacterial infections are associated with increased thrombotic risk, however this correlation is not restricted to pathogenic bacteria.…”
Section: Proteases and Diseasementioning
confidence: 99%
“…The ubiquitin-proteasome pathway (UPP) regulates a variety of critical cellular processes such as transcriptional control, cell cycle progression, protein quality control, oncogenesis, apoptosis, and stress response. Dysfunction of the UPP is associated with many diseases, including cancer, neurodegeneration, autoimmune and inflammatory response, and infectious diseases [1,[16][17][18][19]. As a result of its key functional role, the UPP represents an attractive drug target that has been extensively investigated during the last two decades [20][21][22][23][24][25][26].…”
Section: Introductionmentioning
confidence: 99%